Cite
MLA Citation
Mathias J. Rummel et al.. “A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab‐refractory iNHL (COMPLEMENT A + B study).” British journal of haematology, vol. 193, 2021, pp. 1123–1133. http://access.bl.uk/ark:/81055/vdc_100132665173.0x00005f